Prognostic value of neuroendocrine serum markers and PSA in irradiated patients with pN0 localized prostate cancer
- 31 January 2001
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 46 (2) , 126-133
- https://doi.org/10.1002/1097-0045(20010201)46:2<126::aid-pros1016>3.0.co;2-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- POTENCY, CONTINENCE AND COMPLICATION RATES IN 1,870 CONSECUTIVE RADICAL RETROPUBIC PROSTATECTOMIESJournal of Urology, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate CancerJAMA, 1997
- Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical controlInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Immunoassay and immunohistology studies of chromogranin A as a neuroendocrine marker in patients with carcinoma of the prostateUrology, 1996
- Neuroendocrine differentiation in prostate cancer: Enhanced prediction of progression after radical prostatectomyHuman Pathology, 1996
- Prostate Cancer Clinical Guidelines Panel Summary Report on the Management of Clinically Localized Prostate CancerJournal of Urology, 1995
- The effect of dose on local control of prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Zur Frage der Endokrinie der menschlichen vorsteherdrüseVirchows Archiv, 1944